Off-Label Use of Bumetanide for Brain Disorders: An Overview

Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2019.00310
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Frontiers Media SA

Related search

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Reasons for and Frequency of Off - Label Drug Use

Medicinski Pregled
Medicine
2015English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Off-Label Use of Clonidine for Sedation in Dutch ICUs

Critical Care
Critical CareIntensive Care Medicine
2014English

Medical Liability for Off Label Use of Drugs in Romania

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2018English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment

Anais Brasileiros de Dermatologia
Dermatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy